Xist reduction in breast cancer upregulates AKT phosphorylation via HDAC3-mediated repression of PHLPP1 expression

por Huang, Yen-Sung, Chang, Che-Chang, Lee, Szu-Shuo, Jou, Yuh-Shan, Shih, Hsiu-Ming
Publicado 2016

Pyrimidine metabolic rate limiting enzymes in poorly-differentiated hepatocellular carcinoma are signature genes of cancer stemness and associated with poor prognosis

por Yeh, Hsi-Wen, Lee, Szu-Shuo, Chang, Chieh-Yu, Hu, Chun-Mei, Jou, Yuh-Shan
Publicado 2017

Prognostic comparative genes predict targets for sorafenib combination therapies in hepatocellular carcinoma

por Ho, Chun-Ming, Lin, Kuen-Tyng, Shen, Roger, Gu, De-Leung, Lee, Szu-Shuo, Su, Wen-Hui, Jou, Yuh-Shan
Publicado 2022

EIF3C-enhanced exosome secretion promotes angiogenesis and tumorigenesis of human hepatocellular carcinoma

por Lee, Hsin-Yi, Chen, Chi-Kuan, Ho, Chun-Ming, Lee, Szu-Shuo, Chang, Chieh-Yu, Chen, Kuan-Ju, Jou, Yuh-Shan
Publicado 2018

Somatic A‐to‐I RNA‐edited RHOA isoform 2 specific‐R176G mutation promotes tumor progression in lung adenocarcinoma

por Chen, Kuan‐Ju, Huang, Jing‐Hsiang, Shih, Jou‐Ho, Gu, De‐Leung, Lee, Szu‐Shuo, Shen, Roger, Hsu, Yu‐Hsuan, Kung, Ying‐Chih, Wu, Cheng‐Yen, Ho, Chun‐Ming, Jen, Hsin‐Wei, Lee, Hsin‐Yi, Lang, Yaw‐Dong, Hsiao, Chen‐Hao, Jou, Yuh‐Shan
Publicado 2022